跳到正文

Larimar Therapeutics, Inc.(LRMR)内部人交易:高管与董事近期交易

过去 18 个月,共有 19 位内部人为 Larimar Therapeutics, Inc.(LRMR)报告了 88 笔 Form 4 交易(最近一笔 2026-11-18)。

日期内部人职务类型股数市值
2026-11-18Clayton RussellChief Medical Officer买入3,322$9,999
2026-11-16SHERMAN JEFFREY W董事买入3,289$10,058
2026-11-12THOMAS FRANK E董事买入8,000$21,800
2026-11-12Celano MichaelChief Financial Officer买入18,460$49,992
2026-11-12Truitt Joseph董事买入3,500$9,792
2026-11-12BEN-MAIMON CAROLEPresident and CEO买入18,050$49,953
2026-11-12Hamilton Thomas Edward董事买入70,000$187,082
2026-11-12Shankar GopiChief Development Officer买入5,000$13,549
2026-11-12Harlow John B. Jr.President and COO买入17,800$49,918
2026-10-01Harlow John B. Jr.President and COO买入50,000$0
2026-07-08Hamilton Thomas Edward董事买入50,000$167,000
2026-03-02DEERFIELD MANAGEMENT COMPANY, L.P.董事买入1.1M$5.4M
2026-03-02SHERMAN JEFFREY W董事买入5,000$25,000
2026-03-02Deerfield Mgmt L.P.董事买入1.1M$5.4M
2026-03-02DEERFIELD PARTNERS, L.P.董事买入1.1M$5.4M
2026-03-02Flynn James E董事买入1.1M$5.4M
2026-03-02Deerfield Private Design Fund III, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Mgmt III, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Healthcare Innovations Fund, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Mgmt HIF, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Private Design Fund IV, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Mgmt IV, L.P.董事买入1.1M$5.4M
2026-03-02DEERFIELD MANAGEMENT COMPANY, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Mgmt L.P.董事买入1.1M$5.4M
2026-03-02DEERFIELD PARTNERS, L.P.董事买入1.1M$5.4M

来源:SEC Form 4 申报文件 · 截至 2026-11-18